B. Grillet

发表

TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis

G. Opdenakker, P. Proost, E. Schutyser, 2006, Laboratory Investigation.

Gelatinase B participates in collagen II degradation and releases glycosylated remnant epitopes in rheumatoid arthritis.

P. E. Van den Steen, G. Opdenakker, B. Grillet, 2005, Advances in experimental medicine and biology.

Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post‐translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis

P. E. Van den Steen, G. Opdenakker, P. Proost, 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Selective induction of CCL18/PARC by staphylococcal enterotoxins in mononuclear cells and enhanced levels in septic and rheumatoid arthritis

G. Opdenakker, K. Geboes, E. Schutyser, 2001, European journal of immunology.

Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies

M. Parmentier, G. Opdenakker, P. Proost, 2006, Arthritis research & therapy.

Proteoform Analysis of Matrix Metalloproteinase-9/Gelatinase B and Discovery of Its Citrullination in Rheumatoid Arthritis Synovial Fluids

G. Opdenakker, P. Proost, J. Van Damme, 2021, Frontiers in Immunology.

Development and application of a radioimmunoassay for interleukin-8: detection of interleukin-8 in synovial fluids from patients with inflammatory joint disease.

G. Opdenakker, J. Van Damme, A. Herman, 1992, Laboratory investigation; a journal of technical methods and pathology.

Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis.

G. Opdenakker, J. Van Damme, S. Masure, 1991, Lymphokine and cytokine research.

Do we need to lower the cut point of the 2010 ACR/EULAR classification criteria for diagnosing rheumatoid arthritis?

D. van Zeben, A. Gerards, J. Luime, 2016, Rheumatology.

Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial

D. van Zeben, M. V. van Krugten, P. D. de Jong, 2016, Annals of the rheumatic diseases.

Synergistic induction of CXCL9 and CXCL11 by Toll‐like receptor ligands and interferon‐γ in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids

G. Opdenakker, P. Proost, E. Schutyser, 2004, Journal of leukocyte biology.

Gelatinase B in chronic synovitis: immunolocalization with a monoclonal antibody.

J. Dequeker, G. Opdenakker, B. van Damme, 1997, British journal of rheumatology.

Ileocolonoscopy and spondarthritis.

P. Rutgeerts, J. Dequeker, K. Geboes, 1988, British journal of rheumatology.

Intra-Articular Steroid Injection

J. Dequeker, B. Grillet, 1990 .

Rheumatologists’ adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remission

Y. Goekoop-Ruiterman, C. Allaart, P. Kerstens, 2016, Clinical Rheumatology.

Rheumatoid lymphedema.

J. Dequeker, B. Grillet, 1987, The Journal of rheumatology.

Microbial Toll‐like receptor ligands differentially regulate CXCL10/IP‐10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN‐γ and provide a mechanism for enhanced synovial chemokine levels in septic arthritis

G. Opdenakker, P. Proost, J. Damme, 2003, European journal of immunology.

Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost-utility analysis of the tREACH trial.

D. van Zeben, A. Gerards, J. Luime, 2016, Rheumatology.

The Impact of a Group-Based Multidisciplinary Rehabilitation Program on the Quality of Life in Patients With Fibromyalgia

D. De Bacquer, K. Matthys, B. Grillet, 2019, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study)

C. Allaart, H. Ronday, M. Westedt, 2012, Annals of the rheumatic diseases.

A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study

C. Allaart, T. Huizinga, T. Huizinga, 2013, Annals of the rheumatic diseases.

Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial

D. van Zeben, A. Gerards, J. Luime, 2012, Annals of the rheumatic diseases.

Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study)

Y. Goekoop-Ruiterman, C. Allaart, J. V. van Groenendael, 2016, Arthritis Research & Therapy.

Patient preferences for treatment: report from a randomised comparison of treatment strategies in early rheumatoid arthritis (BeSt trial)

B. Dijkmans, Y. Goekoop-Ruiterman, J. D. de Vries-Bouwstra, 2007, Annals of the rheumatic diseases.

Y. Goekoop-Ruiterman, C. Allaart, T. Huizinga, 2013, Arthritis Research & Therapy.

Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study

C. Allaart, J. V. van Groenendael, T. Huizinga, 2017, Annals of the rheumatic diseases.

Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis

B. Dijkmans, Y. Goekoop-Ruiterman, J. D. de Vries-Bouwstra, 2008, Annals of the rheumatic diseases.

Systematic ileocolonoscopy and bowel biopsy study in spondylarthropathy.

P. Rutgeerts, J. Dequeker, K. Geboes, 1987, British Journal of Rheumatology.

Portal Benefits and risks of targeted treatment in rheumatoid arthritis

C. Allaart, H. Kroon, W. Lems, 2012 .

Human gelatinase B, a marker enzyme in rheumatoid arthritis, is inhibited by D-penicillamine: Anti-rheumatic activity by protease inhibition

K. Norga, G. Opdenakker, S. Masure, 2005, Clinical Rheumatology.

Matrix metalloproteinases in arthritis: towards precision medicine

G. Opdenakker, P. Proost, J. Van Damme, 2023, Nature Reviews Rheumatology.

Can we prevent rapid radiological progression in patients with early rheumatoid arthritis?

C. Allaart, H. Ronday, T. Huizinga, 2014, Clinical Rheumatology.

A clinical and sero-epidemiological study of 190 Belgian patients suffering from Lyme borreliosis.

F. Roger, M. Dupuis, R. Westhovens, 1989, Acta clinica Belgica.

Large-joint damage in patients with early rheumatoid arthritis and its association with treatment strategy and damage of the small joints.

C. Allaart, P. Kerstens, K. Han, 2012, Rheumatology.